fundamental research of the cause of inflammatory bowel disease on Caco-2 cells mucosal model
fundamental research of the cause of inflammatory bowel disease on Caco-2 cells mucosal model
批准号:
15591895
负责人:
SAWAI Toshio
金额:
$1.92万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004
中文摘要
在威尔斯孔上形成Caco-2细胞(人结肠癌细胞)的粘液瘤模型。制备4个组并孵育48小时和72小时。一种是不加细胞因子的黏膜模型,另一种是加IL-1、IL-6、TNF-α的黏膜模型。提取各组大鼠胃粘膜RNA含量。用北方印迹法检测各组细胞内磷脂酶A2 mRNA的表达,并与β-actin的相对表达量进行比较。48 h时IL-6组细胞内磷脂酶A2 mRNA表达较其他各组明显增加。72 h时TNF-α组细胞内磷脂酶A2 mRNA表达明显高于其他各组。在transwell上建立有/无细胞因子的粘膜上皮细胞模型,测定细胞因子作用后6、12、24、72 h的跨上皮电阻(TEER),IL-6组TEER显著高于对照组(P < 0. 05),IL-6组TEER显著高于对照组(P < 0. 05),IL-6组TEER显著高于对照组(P < 0. 05)。 关于我们 OL组分别于6、12、24 h处死。72 h时IL-1和IL-6组的TEER较对照组显著降低。促炎细胞因子IL-6可增加细胞内和培养液中sPLA 2(磷脂酰胆碱水解物)的表达。使用薄层色谱法分析培养基和细胞裂解物的PL组成。两组间培养基中的PL组成没有显示出任何差异。细胞内磷脂总含量也无变化,但IL-6可导致磷脂组成的显著变化,包括磷脂酰乙醇胺(PE)和鞘磷脂(SM)的增加以及磷脂酰胆碱(PC)和溶血磷脂酰胆碱(LPC)的减少(p<0.05)。PE和SM均为炎症信号因子,与IBD的发病密切相关,本研究提示细胞因子可改变炎症介质的黏膜通透性,但这种改变可能不是磷脂酶A2分解磷脂形成溶血磷脂的作用。少
英文摘要
Mucosal model of Caco-2 cells, human colon cancer cells, was formed on wells. The 4 groups were made and incubated for 48 hours and 72 hours. One is that mucosal model was incubated without cytokine, another is that mucosal model was incubated with IL-1, the other with IL-6, the forth with TNF-α. The content of RNA was extracted from mucosa of each group. The expression of intracellular phospholipase A2 mRNA of each group was measured with Northern Blot, compared to the relative expression of β-actin. The expression of intracellular phospholipase A2 mRNA of IL-6 group was significantly increased than the others at 48 hours. At 72 hours, the expression of intracellular phospholipase A2 mRNA of TNF-α group was significantly increased than the others. Mucosal models were made on transwells with/without cytokine, to measure the transepithelial electrical resistance (TEER) at 6, 12, 24, 72 hours after the addition of cytokine.The TEER of IL-6 group was significantly higher compared to contr … More ol group at 6,12,24 hours. At 72 hours, the TEER of IL-1 and IL-6 group was significantly decreased than the control group. The proinflammatory cytokine IL-6 increased the expression of sPLA2 (a hydrolyzer of phosphatidylcholine) of both intracellular and media.Mucosal models were incubated for 72 h with IL-6 or media alone (control). Both media and cell lysate were analyzed for PL composition using thin-layer chromatography. The PL composition in the media did not show any differences between the two groups. Total intracellular PL contents were also unchanged ; however, IL-6 led to significant changes in PL composition including an increase in phosphatidylethanolamine(PE) and sphingomyelin(SM) and a decrease in phosphatidylcholine(PC) and lysophosphatidylcho-line(LPC) (p<0.05). Both PE and SM are known as inflammatory signaling factors involved in human IBD.Our study suggests that cytokine may change the mucosal permeability, however this change may not be the effect of lysophospholipids made from phospholipids by phospholipase A2. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
健脾益髓解毒方下调S100A9介导NLRP3/IL-1β信号通路改善骨髓增生异常综合征造血微环境机制研究
-
批准号:JCZRQNB202600675
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
矾冰纳米乳靶控NLRP3介导IL-1β/TGF-β1轴清透“热气留滞”生肌不致成瘢的机制研究
-
批准号:2026JJ82090
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:魏源水
-
依托单位:
早产儿脑白质损伤的 MRI 影像学特征联合炎症因子组合(IL-6、TNF-α、IL-1β)与神经系统损害关联研究
-
批准号:JCZRLH202601761
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于NLRP3/IL-1β/TGF-β1信号通路调控细胞焦亡探讨柴胡清肝汤治疗肉芽肿性乳腺炎的作用机制
-
批准号:2026JJ82398
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:吴世婷
-
依托单位:
炎症因子组合(IL-6、TNF-α、IL-1β)动态监测在极低出生体重儿坏死性小肠结肠炎早期预测中的价值研究
-
批准号:JCZRLH202601488
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
煨脓生肌理论下糖足生肌散外敷联合保守性锐器清创调控NLRP3/IL-1β轴治疗2型糖尿病足溃疡(湿热毒盛证)的机制研究
-
批准号:2026JJ81429
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:梁玉兰
-
依托单位:
局灶性TBI早期IL-1β调控星形胶质细胞IL-1R1/NF-κB/LCN2信号通路造成脑损伤的机制研究
-
批准号:JCZRYB202500873
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
肠道微生物通过NLRP3/IL-1β通路介导血管内皮损伤在川崎病及其冠状动脉病变中的作用机制研究
-
批准号:JCZRLH202500452
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
靶向PGE2/CREBL2调节IL-1β+TAM分化抑制结直肠炎癌转变的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:王俊
-
依托单位:
炎症因子IL-1β介导线粒体DNA释放抑制牛病毒性腹泻病毒复制的分子机制研究
-
批准号:QN25C180008
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:王孟孟
-
依托单位: